These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3781908)

  • 21. Enkephalinase inhibitors. 1. 2,4-Dibenzylglutaric acid derivatives.
    Ksander GM; Diefenbacher CG; Yuan AM; Clark F; Sakane Y; Ghai RD
    J Med Chem; 1989 Dec; 32(12):2519-26. PubMed ID: 2585440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
    Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
    J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
    Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
    J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of calf-brain enkephalinase A and B.
    van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W
    Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel amidino-substituted benzimidazoles: synthesis of compounds and inhibition of dipeptidyl peptidase III.
    Agić D; Hranjec M; Jajcanin N; Starcević K; Karminski-Zamola G; Abramić M
    Bioorg Chem; 2007 Apr; 35(2):153-69. PubMed ID: 17174378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
    Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
    J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis of N alpha-(4-methylbenzoyl)-4-amidinophenyl-alaninamides and -esters].
    Vieweg H; Wagner G
    Pharmazie; 1983 Mar; 38(3):170-1. PubMed ID: 6867076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and characterization of the novel fluorescent prolyl oligopeptidase inhibitor 4-fluoresceinthiocarbamoyl-6-aminocaproyl-L-prolyl-2(S)-(hydroxyacetyl)pyrrolidine.
    Venäläinen JI; Wallén EA; Poso A; García-Horsman JA; Männistö PT
    J Med Chem; 2005 Nov; 48(23):7093-5. PubMed ID: 16279765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide sweeteners. 6. Structural studies on the C-terminal amino acid of L-aspartyl dipeptide sweeteners.
    Tsang JW; Schmied B; Nyfeler R; Goodman M
    J Med Chem; 1984 Dec; 27(12):1663-8. PubMed ID: 6502595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
    Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
    Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group.
    Cai SX; Guan L; Jia S; Wang Y; Yang W; Tseng B; Drewe J
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5295-300. PubMed ID: 15454214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
    Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
    Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.
    Thaisrivongs S; Tomasselli AG; Moon JB; Hui J; McQuade TJ; Turner SR; Strohbach JW; Howe WJ; Tarpley WG; Heinrikson RL
    J Med Chem; 1991 Aug; 34(8):2344-56. PubMed ID: 1875334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.
    Llorens C; Gacel G; Swerts JP; Perdrisot R; Fournie-Zaluski MC; Schwartz JC; Roques BP
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1710-6. PubMed ID: 7004444
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M; Bachar E; Vogel Z; Blumberg S
    Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racemization in peptide synthesis. A laboratory experiment for senior undergraduates.
    Benoiton NL; Kuroda K; Chen FM
    Int J Pept Protein Res; 1980 May; 15(5):475-9. PubMed ID: 7440056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthesis of N-alpha-(arylsulfonyl)-4-amidino-phenylalanyl-prolines and N-alpha-(arylsulfonylglycyl)-4-amidino-phenylalanyl-prolines and testing of them as inhibitors of serine proteinases. 33. Synthetic inhibitors of serine proteinases].
    Voigt B; Stürzebecher J; Wagner G; Markwardt F
    Pharmazie; 1988 Jun; 43(6):412-4. PubMed ID: 2974999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.